CPM may be a rational choice for patients with known BRCA mutations, patients who have received therapeutic chest radiation, and some mastectomy patients.
Todd M. Tuttle, MD
Advertisement
Articles by Todd M. Tuttle, MD
Advertisement
Latest Updated Articles
- Counseling Breast Cancer Patients on Contralateral Prophylactic Mastectomy: The Physician's Role
Published: April 30th 2008 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Botensilimab/Balstilimab Exhibits Meaningful Activity in Ovarian Cancer
2
FDA Approves Subcutaneous Mosunetuzumab in R/R Follicular Lymphoma
3
Why is Lymphedema Detected So Late in Breast Cancer?
4
Novel Agent Shows Early Activity in Phase 2 Recurrent Thymoma Study
5